Atp11p is a molecular chaperone of the mitochondrial matrix that participates in the biogenesis pathway to form F 1 , the catalytic unit of the ATP synthase. Affinity tag pull-down assays and yeast two-hybrid screens have shown that Atp11p binds to free ␤ subunits of F 1 (Wang, Z. G., and Ackerman, S. H. (2000) J. Biol. Chem. 275, 5767-5772). This binding action prevents the ␤ subunit from associating with itself in non-productive complexes and fosters the formation of a (␣␤) 3 hexamer. Following the premise that Atp11p action is mediated primarily through a surface (as opposed to specific amino acids, as in an enzyme active site), solving its three-dimensional structure so that we may learn how the shape of the protein influences its function is a high priority. Recombinant yeast Atp11p has proven refractory for such analysis because of the presence of a disordered region in the protein. In this article, we show that removal of 67 residues from the amino terminus of recombinant Atp11p yields a subfragment of the protein (called Atp11p TRNC ) that retains molecular chaperone function as determined in vitro with both a surrogate substrate (reduced insulin) and the natural substrate (F 1 ␤). Moreover, preliminary 15 N-1 H heteronuclear single quantum coherence spectra obtained with Atp11p TRNC indicate that the truncated protein is well ordered and amenable to structure determination by nuclear magnetic resonance.
Atp11p was first identified in studies of Saccharomyces cerevisiae mutants that are respiratory deficient because of a defect in mitochondrial F 1 assembly (1) . In normal cells, F 1 is formed of five different types of subunits that assemble an ␣ 3 ␤ 3 ␥␦⑀ oligomer (2) . In this structure, the ␣ subunits and ␤ subunits are arranged, in alternate position, in a hexamer that accounts for ϳ90% the mass of F 1 (3, 4) . The ␣ 3 ␤ 3 structure is not observed to any significant degree in mitochondria from atp11 mutants, instead, such yeast accumulate F 1 ␣ and ␤ subunits as large, insoluble aggregates in the matrix of the organelle (1) . This particular phenotype is observed also in yeast cells deficient for Atp12p, another protein of the F 1 biogenesis pathway (1) . Other instances of F 1 protein aggregation occur in yeast null mutants that are missing either the ␣ or ␤ subunit, because such strains accumulate the lone ␤ or ␣ subunit as aggregated proteins inside mitochondria (1) . In contrast, absence of the ␥ subunit does not correlate with aggregation of ␣ and ␤ subunits (5) . Cumulatively, these observations are consistent with the idea that ␥ assembles with some sort of a soluble ␣ ␤ structure that is formed at an earlier step in the pathway in a manner that is dependent on the actions of Atp11p and Atp12p molecular chaperones.
Atp11p interacts with the nucleotide-binding domain of unassembled ␤ subunits of F 1 (6) . Information about the steric and chemical nature of surfaces in the protein that mediate this binding interaction will be forthcoming once the threedimensional structure of Atp11p is solved. Progress in this area has been hampered by our inability to crystallize Atp11p from preparations of the recombinant protein. In this article, we report the purification and characterization of an Atp11p subfragment that exhibits molecular chaperone activities with model and natural substrates that are comparable with those of the full-length protein. Atp11p TRNC prevents the aggregation of insulin B-chains that are liberated when the disulfide bonds of the hormone are reduced. In other work, the interaction of Atp11p TRNC with the F 1 ␤ subunit is revealed in protein affinity blotting studies. Finally, we report that Atp11p TRNC shows great promise for structure determination by nuclear magnetic resonance as indicated by 15 N-1 H HSQC 1 spectral data that have been obtained with isotopically labeled protein.
EXPERIMENTAL PROCEDURES
Plasmid Construction-The Escherichia coli expression plasmid constructed for this work, pATP11/Xa, produces yeast Atp11p with a His 6 -tag at the amino terminus and a Factor Xa cleavage site inserted between Lys-106 and Ser-107 in the protein sequence (sequence numbering as reported in ref. 7) . The ATP11 DNA was subcloned from plasmid pTRC/ATP11 (8); pTRC/ATP11 carries codons 41-318 of Atp11p, corresponding to the mature protein without its mitochondrial leader sequence, ligated in-frame to an initiator ATG provided by the plasmid. In the first step, pTRC/ATP11 was digested partially with NcoI, and the pool of 5-kb linearized plasmid DNA was gel purified. The partially cut DNA was next digested to completion with BamHI, and the 860-bp NcoI-BamHI product of this digestion was cloned in NcoI, BamHI-cut pPROEX Hta to yield plasmid pPROEX/ATP11. PCR was used to insert a Factor Xa recognition site inside the ATP11 coding sequence of pPROEX/ATP11. Two complementary oligonucleotides were constructed and used as primers for PCR mutagenesis following the QuikChange method (Stratagene). The sense and antisense primers, 5Ј-CATTTGATGACGAAAATCGAAGGTCGTTCTAGAAGTCCT-CTCGATCCA-3Ј and 5Ј-TGGATCGAGAGGACTTCTAGAACGACCTT-CGATTTTCGTCATCAAATG-3Ј, respectively, included ATP11 nucleotides 304 -318, followed by 12 nucleotides (bold) coding for the Factor Xa recognition sequence IEGR, followed by ATP11 nucleotides 319 -339. The primers also encoded a silent (A3 T) bp change (underlined) in the codon for Ser107, which introduced an XbaI restriction site unique to the mutant plasmid. The PCR reaction (50 l) contained 20 * The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed: 421 E. Canfield Ave., Detroit, MI 48201. Tel.: 313-577-8645; Fax: 313-577-7642; E-mail: sackerm@med.wayne.edu. mM Tris-HCl, pH 8.8, 10 mM KCl, 10 mM NH 4 (SO 4 ) 2 , 2 mM MgSO 4 , 0.1% Triton X-100, 0.1 mg/ml bovine serum albumin, 50 ng pPROEX/ATP11 plasmid (DNA template), and 125 ng of each primer. After the reaction was incubated at 95°C for 2 min and then allowed to slowly cool to room temperature, 3 l of QuikSolution (Stratagene), 6 l of 2 mM dTNP mixture, and 1 l of Pfu Turbo (2.5 units) were added to the tube, and the tube was incubated at 68°C for 5 min. Next, PCR was performed for 18 cycles (95°C for 1 min, 55°C for 1.5 min, 68°C for 12 min). The resultant mixture was digested with DpnI at 37°C for 1 h to destroy the original plasmid DNA template, after which 10 l was used to transform competent E. coli cells. Bacterial colonies harboring the mutant plasmid (called pATP11/Xa) were identified by restriction analysis with XbaI and tested in small-scale experiments for isopropyl-1-thio-␤-D-galactopyranoside-induced production of recombinant protein. One such expressing clone was selected and used for large-scale production/purification of the modified Atp11p protein (His 6 Atp11p Xa ). DNA sequencing confirmed the correct position of the inserted Factor Xa cleavage site and showed there were no codon changes elsewhere in the gene for His 6 Atp11p
Xa .
Purification of Recombinant Atp11p and Preparation of a Factor Xa Cleavage Product, Atp11p
TRNC -E. coli strain RRI served as host for the production of unlabeled recombinant proteins. Unmodified Atp11p was produced from the expression vector pTRC/ATP11 (8) and His 6 Atp11p Xa was produced from plasmid pATP11/Xa (described above). Growth of bacterial cultures in 2ϫ yeast tryptone medium, induction of plasmid expression with isopropyl-1-thio-␤-D-galactopyranoside, cell breakage by sonic irradiation, and purification of Atp11p proteins from clarified cell extracts following sequential chromatographic steps through DEAE and CM Fast Flow-Sepharose were as described by White and Ackerman (8) with the following modifications: the concentration of isopropyl-1-thio-␤-D-galactopyranoside used for induction was 0.6 mM; the buffer employed up to and including the DEAE column was 20 mM Tris-HCl, pH 7.5, 1 mM EDTA; lysozyme was omitted from the cell-breaking step; the CM column was run with a continuous gradient of phosphate buffer (50 to 500 mM KPO 4 , pH 7.5, 1 mM EDTA). Highly purified Atp11p or His 6 Atp11p
Xa eluted from CM in ϳ300 mM KPO 4 , pH 7.5, 1 mM EDTA. Unmodified Atp11p was dialyzed versus 20 mM Tris-HCl, pH 7.5, before being concentrated (see below). Atp11p TRNC was prepared from His 6 Atp11p Xa in the following manner. Factor Xa was added directly to the CM column eluate at a protein/ protein ratio of 1:2500 Factor Xa/His 6 Atp11p
Xa and the solution was dialyzed against 4 liters of 20 mM Tris-HCl, pH 8.0, overnight at 4°C. The dialysate was adjusted to pH 8.0 (if necessary) and applied to a cobalt column (1.5 ϫ 5 cm; ϳ9-ml bed volume) (TALON resin; Clontech) that had been pre-equilibrated with 20 mM Tris-HCl, pH 8.0. The column was washed with 60 ml of the equilibration buffer, and the flow-through was collected and passed through a p-amino-benzamidine column (1 ϫ 2.5 cm; ϳ2-ml bed volume) (Sigma) to remove Factor Xa from the protein preparation. Purified preparations of unmodified Atp11p and Atp11p
TRNC were concentrated to 10 to 15 mg/ml using a Centricon-10, flash-frozen in liquid N 2 , and stored at Ϫ80°C.
Preparation of 15 N-Atp11p and 15 N-Atp11
TRNC -Bacterial strain BL21 was used to propagate expression plasmids for preparation of recombinant Atp11p proteins labeled with 15 N. Transformed bacteria were grown overnight at 37°C in LB ϩ ampicillin (40 g/ml) and harvested the next morning by centrifugation at 4000 ϫ g for 10 min at 4°C. The cell pellet was resuspended with 2 ml of M9 media, inoculated into 500 ml of M9 ϩ ampicillin (40 g/ml) medium, and the culture was grown at 37°C to an A 600 ϭ 0.8. The cells were collected by centrifugation and inoculated into 2 liters of M9 ϩ ampicillin media that was prepared with 15 NH 4 Cl (Cambridge isotopes) in place of unlabeled ammonium chloride. The labeled cultures were grown at 37°C to mid-log phase, at which point isopropyl-1-thio-␤-D-galactopyranoside (1 mM) was added to induce production of , from E. coli lysates followed the methods described except that the final step involved dialysis of the recombinant protein solutions against 10 mM Na 2 PO 4 , pH 7.0, before concentration to 15 mg/ml in a Centricon-10.
Nuclear Magnetic Resonance-Two-dimensional Protein Affinity Blots-The subunits of purified yeast F 1 were resolved in an SDS-polyacrylamide gel as described previously (9) and transferred electrophoretically to nitrocellulose membrane. The blot was washed three times for 10 min each with 20 mM Tris-HCl, pH 7.5, 500 mM NaCl, 1% Tween 20 (TBST) and then blocked for 30 min with a solution of TBST plus 1.5% milk. After removal of the blocking solution, the blot was overlaid with 10 ml of fresh TBST/milk that was supplemented with purified Atp11p protein (20 g) and agitated on a rotary shaker at room temperature for 2 h. The protein solution was collected and the blot was washed with TBST three times for 10 min each. Next, polyclonal antibody against yeast Atp11p was added to the blot at 1:2000 dilution in 10 ml TBST/milk and allowed to react for 1 h. After this step, the blot was washed with TBST and then challenged with horseradish-conjugated goat anti-rabbit secondary antibody in TBST/ milk for 30 min. After this reaction, the blot was washed with TBST, and immunologically reactive protein was detected with chemiluminescent reagents (Amersham Biosciences).
Miscellaneous Procedures-The light scattering assay for insulin B- chain aggregation was performed as described previously (10) . Protein was estimated using the procedure of Lowry (11) .
RESULTS AND DISCUSSION

Preparation of a Recombinant Atp11p Subdomain (Atp11p
TRNC )-In previous work (12), we assigned the boundaries of four domains in the polypeptide chain of Atp11p, which include the mitochondrial leader sequence (residues 1-39), the N-terminal domain (NTD, residues 40 -111), the functional domain (residues 112-183), and the C-terminal domain (residues 184 -318) (Fig. 1) . Our standard preparation of recombinant yeast Atp11p purified from bacteria lacks the targeting sequence and encompasses codons 41-318 of the primary gene product (8) . Such preparations are highly pure and active in biochemical assays of Atp11p activity (see ref. 10 and below). However, the recombinant yeast protein does not crystallize and this has hampered our efforts to pursue the determination of its three-dimensional structure by x-ray diffraction methods. In preliminary work to determine whether nuclear magnetic resonance might be an avenue to study Atp11p structure, A strategy based on known features of Atp11p was developed to allow the preparation of a stable subfragment that might be more amenable to structure analysis. The decision was made to remove the protease-hypersensitive NTD (Fig. 1 ) from the protein (see ref. 12) . Complementation studies have shown that the NTD is not required for the chaperone action of Atp11p in yeast cells (12) , and the extreme hydrophilic character of this region was considered to be the principle factor causing disorder of the protein structure. Efforts to produce a truncated protein directly from an expression vector did not yield detectable levels of the protein in bacterial cell lysates. This finding is consistent with the observation that although N-terminally truncated forms of Atp11p retain function, they are much less physically stable in vivo relative to the full-length protein (12) . To overcome this problem, recombinant Atp11p was engineered with a Factor Xa cleavage site (IEGR ) near the end of the NTD, in-between Lys106 and Ser107 ( Fig. 2A) . The protein was also modified with a His 6 -tag at the amino terminus. In the purification scheme (see "Experimental Procedures"), His 6 Atp11p Xa is prepared from bacteria, and after digestion with Factor Xa, truncated Atp11p (Atp11p TRNC , Ser-107 through Asn-318) is purified from the His 6 NTD and from any undigested protein after passage of the digested mixture through a cobalt column, which binds the His 6 sequence (Figs. 2, A and B) . Subsequent chromatography of Atp11p TRNC through p-amino benzamidine agarose removes Factor Xa from the preparation and yields the highly purified subfragment Atp11p TRNC (Fig. 2B, lane 3) .
Atp11p
TRNC Prevents Aggregation of Reduced Insulin B-chains-The molecular chaperone activity of Atp11p can be assessed in vitro using reduced insulin as a surrogate substrate (10) . In this method, light scattering is used to follow the progression of insulin B-chain aggregation that occurs when the disulfide bonds in the hormone are reduced with dithiothreitol (13) . Atp11p TRNC provides Ͼ60% protection against aggregation to reduced insulin B-chains in this assay (Fig. 3) . This result can be compared with the value of 70% protection that is obtained with full-length recombinant Atp11p in similar studies (10). Atp11p TRNC is just five residues shorter at the amino terminus than Atp11(⌬40 -111)p (12), a plasmid-borne variant of Atp11p that has been shown to confer respiratory competence to a ⌬ atp11 yeast mutant in previous work. Hence, there is excellent correlation of results obtained in vivo and in vitro to support the argument that removal of the Atp11p NTD does not interfere significantly with the molecular chaperone activity of the protein.
Interactions between Atp11p and F 1 ␤ Proteins Studied by Affinity Blotting-Atp11p binds to the ␤ subunit of F 1 in yeast cells (6) but not to a preparation of recombinant mitochondrial ␤ subunit that is solubilized from bacteria with alkaline buffer after export to the periplasmic face of the plasma membrane. 2 A likely reason for this observation is that the alkaline-extracted protein poorly reflects the character of the ␤ subunit that is presented to Atp11p during F 1 assembly. Protein affinity blotting has provided an alternative method to study Atp11p interaction with its natural substrate in vitro. In this work, purified yeast F 1 was run in an SDS gel under conditions that maximize resolution between ␣ and ␤ subunits (9), after which the proteins were transferred to nitrocellulose (NC) membrane (Fig. 4) . The NC was first incubated in TBST (see "Experimental Procedures") and then treated with TBST/milk to reduce nonspecific protein binding. Next, the blocked NC was incubated with purified Atp11p (full-length or truncated subdomain) in TBST/milk, and after the protein overlay solution was removed, it was immunoblotted with antiserum against Atp11p. Atp11p (31 kDa) and Atp11p TRNC (24 kDa) were detected with the antibody at the position of (55 kDa) in the blot (Fig. 4, lanes 1 and 2) . The Atp11p protein signals were not detected if immunoblotting was done using pre-immune rabbit serum instead of anti-Atp11p serum (Fig. 4,  lane 3) . Moreover, under conditions in which the incubation step with purified Atp11p was omitted from the experiment and the NC was instead exposed directly to Atp11p antiserum, there was no immunoreactive signal (Fig. 4, lane 4) . Such findings illustrate that anti-Atp11p does not recognize epitopes in the F 1 ␤ subunit; rather, the antibody lights up Atp11p bound to the F 1 ␤ subunit immobilized on the NC blot. The fact that the ␤ subunit, which binds Atp11p in this assay, has been resolved from other F 1 subunits in an SDS gel is not inconsistent with our model for Atp11p action, which suggests the chaperone recognizes a structural element in its target protein (14) . There are examples in the literature of protein, transferred from an SDS gel to NC paper, that retains or regains sufficient higher order structure to support an interaction with nucleic acid (15) or protein (16, 17) applied as an overlay solution to the blot. It is possible that either the F 1 ␤ subunit is not completely denatured in the SDS gel or it renatures partially after electrophoretic transfer from the denaturing gel and subsequent washing of the NC membrane. A corollary finding of this analysis is that the Atp11p:F 1 ␤ binding interaction occurs in the absence of other proteins or cofactors. The dependence of chaperone release on other factors remains to be determined.
Nuclear Magnetic Resonance Studies with Atp11p TRNC -15 N-labeled Atp11p TRNC (212 amino acids) yields a very well resolved 15 N-1 H HSQC spectrum at 25°C, from which 200 strong main-chain cross peaks can be easily counted (Fig. 5) . Their peak intensity and line-width is rather uniform. Lower level plots reveal another 10 resolved low intensity peaks. Together, the data are indicative of a structured protein, without mobile tails, and with few exchange broadened peaks. Using one-dimensional variants of standard 15 N relaxation experiments, 15N T 2 ϭ 0.043 Ϯ 0.005 s, and 15N T 1 ϭ 1.4 Ϯ 0.2 s at 25°C were found for resonances with a 1 H chemical shift at 9 ppm (i.e. resonances belonging to the structured core of the protein). This yields a value of 14 Ϯ 2 ns for the protein's rotational correlation time, corresponding to a molecular mass of 28 Ϯ 4 kDa, which is near the value of 24 kDa calculated from the sequence of Atp11p TRNC . It may be inferred from the spectral data that the protein is mono-disperse at the concentrations (24 mg/ml) used in the experiment. The prospects for NMR assignment and solution structure determination of Atp11p TRNC , once uniformly triple-labeled with 15 N, 2 H, and 13 C, are excellent. Having demonstrated here that the purified subfragment of Atp11p shows functional activities comparable with the full-length protein, there is every reason to believe that solving the solution structure of Atp11p TRNC will provide relevant information about the mechanism of this molecular chaperone. 
